Metformin Hydrochloride
- Product NDC
- 70518-4710
- Requested package NDC
- 70518-4710-0
- 11-digit product format
- 705184710
- Labeler code
- 70518
- Product ID
- 70518-4710_57ae80ca-b1b2-d40e-e063-6294a90aa303
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metformin Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA209694
- Marketing category
- ANDA
- Marketing start
- 2026-07-28
- Substance
- METFORMIN HYDROCHLORIDE
- Active strength
- 1000 mg/1
- Pharmacologic classes
- Biguanide [EPC]; Biguanides [CS]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209694-001 | METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB2 | 2024-10-18 | |
| A209694-002 | METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB2 | 2024-10-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209694-001 | AB2 |
| A209694-002 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209694-001 | METFORMIN HYDROCHLORIDE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB2 | 2024-10-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209694-002 | METFORMIN HYDROCHLORIDE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB2 | 2024-10-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209694-001 | AB2 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209694-002 | AB2 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | e22a8545-86a6-439e-a758-29c4d6ed8bfe | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 209694 ANDA209694 70518-4710-0 70518-4710 70518471000 |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | ef77c7dd-a65f-4adc-a0d9-a93779b459a0 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 209694 ANDA209694 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metformin Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METFORMIN HYDROCHLORIDE | 1000 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 786Z46389E | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e22a8545-86a6-439e-a758-29c4d6ed8bfe | Available on FDA.report |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Status |
|---|---|---|---|---|---|---|
| 70518-4710-0 | 70518471000 | 50 POUCH in 1 BOX (70518-4710-0) / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-4710-1) | 50 pouch | 2026-07-28 | 0 | Current |